News Headlines Article

For minority groups, clinical trial strength rests in numbers
San Francisco Business Times

A diverse group of doctors and patient advocates have launched a national campaign to enroll more minorities in clinical trials that could find genetic-based answers and reshape the use of life-saving medicines. The “I’m In” campaign, backed by drug makers through the Pharmaceutical Research and Manufacturers of America, is aimed at bringing more minority patients and their doctors as well as minority researchers into the clinical trial fold.